Ad
related to: dengue fever treatment guidelines childrenamazon.com has been visited by 1M+ users in the past month
Search results
Results From The WOW.Com Content Network
Treatment of dengue fever is symptomatic, as there is no specific treatment for dengue fever. In mild cases, treatment focuses on treating pain. Severe cases of dengue require hospitalisation; treatment of acute dengue is supportive and includes giving fluid either by mouth or intravenously. [1] [2]
Dengue vaccine is a vaccine used to prevent dengue fever in humans. [9] Development of dengue vaccines began in the 1920s but was hindered by the need to create immunity against all four dengue serotypes. [10] As of 2023, there are two commercially available vaccines, sold under the brand names Dengvaxia and Qdenga. [11] [12]
Dengue virus (DENV) is the cause of dengue fever.It is a mosquito-borne, single positive-stranded RNA virus of the family Flaviviridae; genus Flavivirus. [1] [2] Four serotypes of the virus have been found, and a reported fifth has yet to be confirmed, [3] [4] [5] all of which can cause the full spectrum of disease. [1]
While the U.S. does have a dengue vaccine, it’s approved only for children ages 9 to 16 who live in places where dengue is endemic, including Puerto Rico, American Samoa or the U.S. Virgin Islands.
This year, the incidence of dengue fever globally has been the highest on record, especially in Latin American countries, where more than 9.7 million dengue cases have been reported. That's twice ...
There have been more than twice as many cases of dengue fever across North, South and Central America — more than 9.7 million — in the first half of 2024 than there were in all of 2023, ...
Treatment of acute dengue is supportive, using either oral or intravenous rehydration for mild or moderate disease, and intravenous fluids and blood transfusion for more severe cases. The incidence of dengue fever has increased dramatically since the 1960s, with around 50–100 million people infected yearly. Early descriptions of the condition ...
Approximately 800,000 schoolchildren received the Dengvaxia vaccine and benefit from the protection it grants against dengue fever. However around 10% of those 800,000 had not had dengue fever before and therefore are at risk of severe infection because of the vaccine.